On June 27, 2024, BioNxt Solutions Inc. closed the transaction. The company has issued 1,500,000 common shares at a price of CAD 0.27 per share for gross proceeds of up to CAD 405,000 in its third and final tranche closing. The total placement size, cumulative of all tranches, is 3,500,000 common shares for aggregate gross proceeds of CAD 945,000.

The company did not pay any cash finder?s fees or issue any finder?s warrants in connection with closing of the final tranche. All securities issued in connection with closing of the final tranche are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.